Insider Trading activities of Intercept Pharmaceuticals, Inc. (ICPT) , Part 3

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Intercept Pharmaceuticals, Inc. (ICPT) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Intercept Pharmaceuticals, Inc. since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Intercept Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is ICPT. The reporting company's CIK number is 1270073.
The total value of stock buying since 2005 is $72,431,146.
The total value of stock sales since 2005 is $1,286,281,327.
The total value of stock option exercises since 2005 is $12,493,143.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Intercept Pharmaceuticals, Inc. insiders (ICPT) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-11-03 Pruzanski Mark (CEO & President) Sale 10,000 255.79 2,557,880
2014-11-03 Pruzanski Mark (CEO & President) Option Ex 10,000 8.67 86,670
2014-10-16 Akkaraju Srinivas Option Ex 324 .00 0
2014-10-10 Veitinger Klaus R Dr Sale 391 223.65 87,447
2014-10-10 Veitinger Klaus R Dr Option Ex 391 21.50 8,406
2014-10-02 Shapiro David (CMO and EVP - Development) Sale 832 233.97 194,663
2014-10-01 Shapiro David (CMO and EVP - Development) Sale 4,188 230.64 965,924
2014-10-01 Shapiro David (CMO and EVP - Development) Option Ex 5,622 5.20 29,234
2014-10-01 Pruzanski Mark (CEO & President) Sale 10,000 230.49 2,304,850
2014-10-01 Pruzanski Mark (CEO & President) Option Ex 14,867 4.33 64,418
2014-10-01 Adorini Luciano (Chief Scientific Officer) Option Ex 649 .00 0
2014-10-01 Duncan Barbara Gayle (Chief Financial Officer) Sale 1,000 233.90 233,897
2014-10-01 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 2,299 15.95 36,669
2014-09-15 Shapiro David (CMO and EVP - Development) Sale 4,000 283.04 1,132,168
2014-09-15 Shapiro David (CMO and EVP - Development) Option Ex 4,000 10.40 41,600
2014-09-10 Veitinger Klaus R Dr Sale 391 280.50 109,675
2014-09-10 Veitinger Klaus R Dr Option Ex 391 21.50 8,406
2014-09-02 Pruzanski Mark (CEO & President) Sale 10,000 287.47 2,874,700
2014-09-02 Pruzanski Mark (CEO & President) Option Ex 10,000 8.67 86,670
2014-08-27 Shapiro David (CMO and EVP - Development) Sale 10,000 294.67 2,946,710
2014-08-27 Shapiro David (CMO and EVP - Development) Option Ex 10,000 8.67 86,670
2014-08-26 Silverstein Jonathan Sale 61,258 300.74 18,422,424
2014-08-26 Isaly Samuel D Sale 61,258 300.74 18,422,424
2014-08-25 Williams Nicole Sale 2,433 295.08 717,936
2014-08-25 Silverstein Jonathan Sale 50,000 296.01 14,800,500
2014-08-25 Isaly Samuel D Sale 50,000 296.01 14,800,500
2014-08-15 Shapiro David (CMO and EVP - Development) Sale 4,774 290.08 1,384,851
2014-08-15 Shapiro David (CMO and EVP - Development) Option Ex 4,000 10.40 41,600
2014-08-14 Silverstein Jonathan Sale 60,000 300.36 18,021,780
2014-08-14 Isaly Samuel D Sale 60,000 300.36 18,021,780
2014-08-12 Regan Daniel Paul (Chief Commercial Officer) Sale 8,124 325.90 2,647,587
2014-08-12 Regan Daniel Paul (Chief Commercial Officer) Option Ex 8,124 37.69 306,193
2014-08-12 Adorini Luciano (Chief Scientific Officer) Sale 11,038 325.98 3,598,156
2014-08-12 Adorini Luciano (Chief Scientific Officer) Option Ex 11,038 8.67 95,666
2014-08-12 Veitinger Klaus R Dr Sale 316 345.62 109,215
2014-08-12 Veitinger Klaus R Dr Option Ex 316 21.50 6,794
2014-08-11 Fundaro Paolo Sale 324 239.49 77,594
2014-08-11 Veitinger Klaus R Dr Sale 555 237.80 131,977
2014-08-11 Veitinger Klaus R Dr Option Ex 391 21.50 8,406
2014-08-09 Fundaro Paolo Option Ex 324 .00 0
2014-08-09 Veitinger Klaus R Dr Option Ex 324 .00 0
2014-08-09 Williams Nicole Option Ex 368 .00 0
2014-08-09 Silverstein Jonathan Option Ex 324 .00 0
2014-08-09 Isaly Samuel D Option Ex 324 .00 0
2014-08-01 Pruzanski Mark (CEO & President) Sale 10,000 226.72 2,267,200
2014-08-01 Pruzanski Mark (CEO & President) Option Ex 10,000 8.67 86,670
2014-07-16 Akkaraju Srinivas Option Ex 325 .00 0
2014-07-10 Veitinger Klaus R Dr Sale 391 219.69 85,898
2014-07-10 Veitinger Klaus R Dr Option Ex 391 21.50 8,406
2014-07-07 Tallarigo Lorenzo Sale 2,000 243.06 486,110
2014-07-07 Tallarigo Lorenzo Option Ex 2,000 9.82 19,644
2014-07-03 Regan Daniel Paul (Chief Commercial Officer) Sale 1 250.00 250
2014-07-03 Regan Daniel Paul (Chief Commercial Officer) Option Ex 1 37.69 37
2014-07-02 Shapiro David (CMO and EVP - Development) Sale 849 247.65 210,257
2014-07-01 Shapiro David (CMO and EVP - Development) Sale 4,187 244.09 1,022,017
2014-07-01 Shapiro David (CMO and EVP - Development) Option Ex 5,623 5.20 29,239
2014-07-01 Pruzanski Mark (CEO & President) Sale 10,000 250.61 2,506,120
2014-07-01 Pruzanski Mark (CEO & President) Option Ex 14,868 4.33 64,423
2014-07-01 Adorini Luciano (Chief Scientific Officer) Option Ex 649 .00 0
2014-07-01 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 1,298 .00 0
2014-06-16 Shapiro David (CMO and EVP - Development) Sale 4,000 277.60 1,110,396
2014-06-16 Shapiro David (CMO and EVP - Development) Option Ex 4,000 10.40 41,600
2014-06-02 Pruzanski Mark (CEO & President) Sale 10,000 230.60 2,305,990
2014-06-02 Pruzanski Mark (CEO & President) Option Ex 10,000 8.67 86,670
2014-05-15 Shapiro David (CMO and EVP - Development) Sale 4,743 275.53 1,306,819
2014-05-15 Shapiro David (CMO and EVP - Development) Option Ex 4,000 10.40 41,600
2014-05-15 Fundaro Paolo Option Ex 6,922 9.82 67,987
2014-05-09 Fundaro Paolo Sale 325 232.00 75,400
2014-05-09 Fundaro Paolo Option Ex 325 .00 0
2014-05-09 Veitinger Klaus R Dr Sale 162 230.52 37,344
2014-05-09 Veitinger Klaus R Dr Option Ex 325 .00 0
2014-05-09 Tallarigo Lorenzo Sale 367 232.00 85,144
2014-05-09 Tallarigo Lorenzo Option Ex 367 .00 0
2014-05-09 Williams Nicole Option Ex 367 .00 0
2014-05-09 Silverstein Jonathan Option Ex 325 .00 0
2014-05-09 Isaly Samuel D Option Ex 325 .00 0
2014-05-07 Adorini Luciano (Chief Scientific Officer) Sale 2,000 259.44 518,876
2014-05-07 Adorini Luciano (Chief Scientific Officer) Option Ex 2,000 10.40 20,800
2014-05-07 Veitinger Klaus R Dr Sale 665 254.21 169,046
2014-05-07 Tallarigo Lorenzo Sale 1,640 259.48 425,547
2014-05-07 Isaly Samuel D Option Ex 1,330 .00 0
2014-05-01 Pruzanski Mark (CEO & President) Sale 10,000 263.17 2,631,660
2014-05-01 Pruzanski Mark (CEO & President) Option Ex 10,000 8.67 86,670
2014-04-16 Pruzanski Mark (CEO & President) Sale 10,000 242.22 2,422,170
2014-04-16 Pruzanski Mark (CEO & President) Option Ex 10,000 8.67 86,670
2014-04-16 Akkaraju Srinivas Option Ex 324 .00 0
2014-04-15 Pruzanski Mark (CEO & President) Option Ex 30,309 6.74 204,312
2014-04-14 Duncan Barbara Gayle (Chief Financial Officer) Sale 1,154 279.00 321,966
2014-04-14 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 1,154 21.50 24,811
2014-04-10 Micheli Francesco Sale 30,623 293.91 9,000,405
2014-04-10 Genextra S.p.a. Sale 30,623 293.91 9,000,405
2014-04-10 Tallarigo Lorenzo Sale 30,623 293.91 9,000,405
2014-04-09 Micheli Francesco Sale 318,695 320.00 101,982,400
2014-04-09 Genextra S.p.a. Sale 318,695 320.00 101,982,400
2014-04-09 Tallarigo Lorenzo Sale 318,695 320.00 101,982,400
2014-04-09 Silverstein Jonathan Sale 81,305 320.00 26,017,600
2014-04-09 Isaly Samuel D Sale 81,305 320.00 26,017,600
2014-04-07 Adorini Luciano (Chief Scientific Officer) Sale 2,000 283.10 566,200
2014-04-07 Adorini Luciano (Chief Scientific Officer) Option Ex 2,000 10.40 20,800
2014-04-02 Shapiro David (CMO and EVP - Development) Sale 879 321.95 282,996
2014-04-01 Shapiro David (CMO and EVP - Development) Sale 4,514 334.36 1,509,301
2014-04-01 Shapiro David (CMO and EVP - Development) Option Ex 5,948 5.20 30,929
2014-04-01 Pruzanski Mark (President and CEO) Option Ex 4,868 .00 0
2014-04-01 Adorini Luciano (Chief Scientific Officer) Option Ex 649 .00 0
2014-04-01 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 1,298 .00 0
2014-03-17 Shapiro David (CMO and EVP - Development) Sale 4,456 432.48 1,927,135
2014-03-17 Shapiro David (CMO and EVP - Development) Option Ex 8,917 10.40 92,736
2014-03-07 Adorini Luciano (Chief Scientific Officer) Sale 2,000 421.31 842,620
2014-03-07 Adorini Luciano (Chief Scientific Officer) Option Ex 2,000 10.40 20,800
2014-03-05 Regan Daniel Paul (Chief Commercial Officer) Sale 20,000 434.62 8,692,500
2014-03-05 Regan Daniel Paul (Chief Commercial Officer) Option Ex 20,000 37.69 753,800
2014-02-14 Shapiro David (CMO and EVP - Development) Sale 5,772 367.30 2,120,055
2014-02-14 Shapiro David (CMO and EVP - Development) Option Ex 4,327 10.40 45,000
2014-02-14 Fundaro Paolo Sale 324 367.51 119,073
2014-02-12 Fundaro Paolo Sale 6,922 376.26 2,604,492
2014-02-12 Fundaro Paolo Option Ex 6,922 8.67 59,992
2014-02-10 Veitinger Klaus R Dr Sale 162 381.10 61,737
2014-02-10 Tallarigo Lorenzo Sale 368 354.52 130,463
2014-02-09 Fundaro Paolo Option Ex 324 .00 0
2014-02-09 Veitinger Klaus R Dr Option Ex 324 .00 0
2014-02-09 Tallarigo Lorenzo Option Ex 368 .00 0
2014-02-09 Williams Nicole Option Ex 368 .00 0
2014-02-09 Silverstein Jonathan Option Ex 324 .00 0
2014-02-09 Isaly Samuel D Option Ex 324 .00 0
2014-02-07 Adorini Luciano (Chief Scientific Officer) Sale 2,000 306.27 612,546
2014-02-07 Adorini Luciano (Chief Scientific Officer) Option Ex 2,000 10.40 20,800
2014-01-16 Pruzanski Mark (President and CEO) Sale 10,000 273.68 2,736,770
2014-01-16 Pruzanski Mark (President and CEO) Option Ex 10,000 8.67 86,670
2014-01-16 Akkaraju Srinivas Sale 3,250 267.94 870,805
2014-01-16 Akkaraju Srinivas Option Ex 2,825 10.75 30,368
2014-01-15 Duncan Barbara Gayle (Chief Financial Officer) Sale 5,625 263.12 1,480,038
2014-01-15 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 5,625 31.90 179,437
2014-01-08 Shapiro David (CMO and EVP - Development) Sale 4,928 72.32 356,412
2014-01-08 Shapiro David (CMO and EVP - Development) Option Ex 8,968 9.53 85,491
2014-01-07 Adorini Luciano (Chief Scientific Officer) Sale 1,634 67.41 110,147
2014-01-07 Adorini Luciano (Chief Scientific Officer) Option Ex 1,634 10.40 16,993
2014-01-07 Tallarigo Lorenzo Sale 1,839 67.41 123,966
2014-01-01 Shapiro David (CMO and EVP - Development) Option Ex 1,623 .00 0
2014-01-01 Pruzanski Mark (President and CEO) Option Ex 4,868 .00 0
2014-01-01 Adorini Luciano (Chief Scientific Officer) Option Ex 649 .00 0
2014-01-01 Duncan Barbara Gayle (Chief Financial Officer) Option Ex 1,298 .00 0
2013-12-30 Pruzanski Mark (President and CEO) Option Ex 21,503 2.89 62,122
2013-12-18 Akkaraju Srinivas Sale 260 55.52 14,436
2013-12-16 Shapiro David (CMO & EVP - Development) Sale 5,016 62.11 311,548
2013-12-16 Shapiro David (CMO & EVP - Development) Option Ex 3,750 10.40 39,000
2013-11-20 Adorini Luciano (Chief Scientific Officer) Sale 2,000 50.88 101,754
2013-11-20 Adorini Luciano (Chief Scientific Officer) Option Ex 2,000 10.40 20,800
2013-11-15 Shapiro David (CMO & EVP - Development) Sale 4,730 48.08 227,413
2013-11-15 Shapiro David (CMO & EVP - Development) Option Ex 3,750 10.40 39,000
2013-11-11 Veitinger Klaus R Dr Sale 162 48.91 7,923
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of ICPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Intercept Pharmaceuticals, Inc. (symbol ICPT, CIK number 1270073) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month